U.S. Stem Cell, Inc. (USRM)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
+0.0001 (0.00%)
At close: Dec 31, 2024
U.S. Stem Cell Market Cap
U.S. Stem Cell has a market cap or net worth of $662.00 as of January 30, 2025. Its market cap has decreased by -99.97% in one year.
Market Cap
662.00
Enterprise Value
n/a
Revenue
82.05K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 19, 2008, U.S. Stem Cell's market cap has decreased from 66.74M to 662.00, a decrease of -100.00%. That is a compound annual growth rate of -49.32%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 2.13B |
| SS Innovations International | 1.55B |
| Veradigm | 1.29B |
| Nika Pharmaceuticals | 1.02B |
| Elite Pharmaceuticals | 500.05M |
| Glass House Brands | 469.08M |
| Northwest Biotherapeutics | 377.51M |
| CytoDyn | 255.23M |